Clinical trial
Efficacy of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP): A Prospective Randomized Study
NCT07204106 is registered in ClinicalTrials.gov with Shiyou Wei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP): A Prospective Randomized Study
- Lead sponsor
- Shiyou Wei
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 2, 2025
- Completion date
- November 12, 2025
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dexmedetomidine induced sedation, nasal administration, sprays